Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis.
- 2002-04-01
- Pediatrics 109(4)
- Cornelius W Van Niel
- C. Feudtner
- Michelle M. Garrison
- D. Christakis
- PubMed: 11927715
- DOI: 10.1542/PEDS.109.4.678
Abstract
Objective: Childhood diarrhea accounts for substantial morbidity and mortality worldwide. Multiple studies in children have shown that Lactobacillus, administered orally, may have antidiarrheal properties. We conducted a meta-analysis of randomized, controlled studies to assess whether treatment with Lactobacillus improves clinical outcomes in children with acute infectious diarrhea.
Methods: Studies were sought in bibliographic databases of traditional biomedical as well as complementary and alternative medicine literature published from 1966 to 2000. Search terms were "competitive inhibition," "diarrhea," "gastroenteritis," "Lactobacillus," "probiotic," "rotavirus," and "yog(h)urt." We included studies that were adequately randomized, blinded, controlled trials in which the treatment group received Lactobacillus and the control group received an adequate placebo and that reported clinical outcome measures of diarrhea intensity. These inclusion criteria were applied by blind review and consensus. The original search yielded 26 studies, 9 of which met the criteria. Multiple observers independently extracted study characteristics and clinical outcomes. Data sufficient to perform meta-analysis of the effect of Lactobacillus on diarrhea duration and diarrhea frequency on day 2 were contained in 7 and 3 of the included studies, respectively.
Results: Summary point estimates indicate a reduction in diarrhea duration of 0.7 days (95% confidence interval: 0.3-1.2 days) and a reduction in diarrhea frequency of 1.6 stools on day 2 of treatment (95% confidence interval: 0.7-2.6 fewer stools) in the participants who received Lactobacillus compared with those who received placebo. Details of treatment protocols varied among the studies. A preplanned subanalysis suggests a dose-effect relationship.
Conclusion: The results of this meta-analysis suggest that Lactobacillus is safe and effective as a treatment for children with acute infectious diarrhea.
Research Insights
Supplement | Health Outcome | Effect Type | Effect Size |
---|---|---|---|
Lactobacillus genseni | Reduced Diarrhea Frequency | Beneficial | Moderate |
Lactobacillus genseni | Reduced Duration of Diarrhea | Beneficial | Moderate |
Lactobacillus jensenii LBV 116 | Reduced Diarrhea Rate | Beneficial | Moderate |
Lactobacillus jensenii LBV 116 | Reduced Duration of Diarrhea | Beneficial | Moderate |
Lactobacillus jensenii VPro 32 | Reduced Diarrhea Frequency | Beneficial | Moderate |
Lactobacillus jensenii VPro 32 | Reduced Duration of Diarrhea | Beneficial | Moderate |
Lactobacillus lactis LLa61 | Reduced Diarrhea Rate | Beneficial | Moderate |
Lactobacillus lactis LLa61 | Reduced Duration of Diarrhea | Beneficial | Moderate |
Lactobacillus sporogenes | Reduced Diarrhea Rate | Beneficial | Moderate |
Lactobacillus sporogenes | Reduced Duration of Diarrhea | Beneficial | Moderate |